Novartis's big bet on sickle cell disease struggles to reach Kenya
Pharma giants are pouring money into new therapies for sickle cell disease but in Kenya, patients struggle to access a decades-old drug.
Source: swissinfo.ch
Fast, Ad-Free News Updates
Stay updated with breaking news from Emaculate Achieng. Real-time updates on events, politics, business and more.